
    
      The purpose of phase 1 of this two phase clinical trial is to determine: 1) the effect of
      decreasing levels of human milk oligosaccharides on fecal B.infantis during and after 21 days
      of supplementation with Evolve activated B.infantis using exclusively breastfed, mixed-fed
      and exclusively formula-fed infants; 2) determine the effect of Evolve activated B.infantis
      on fecal B.infantis levels in exclusively breastfed infants compared to pre-supplementation
      levels.
    
  